{"id":"NCT01875159","sponsor":"American SIDS Institute","briefTitle":"Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm","officialTitle":"Pilot Study of Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2013-06-11","resultsPosted":"2015-03-17","lastUpdate":"2015-03-17"},"enrollment":98,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypoxia"],"interventions":[{"type":"DRUG","name":"Caffeine citrate 6 mg/kg/day","otherNames":["Cafcit"]}],"arms":[{"label":"Caffeine","type":"EXPERIMENTAL"},{"label":"Active Comparator: no caffeine","type":"NO_INTERVENTION"}],"summary":"The purpose of this pilot study is to document the extent to which intermittent hypoxia persists beyond the age of discontinuing clinical methylxanthine, and will assess the effect of caffeine treatment on the number of intermittent hypoxia episodes and the total number of seconds with a hemoglobin oxygen saturation (HbO2 SAT) below 90%.","primaryOutcome":{"measure":"Episodes of Intermittent Hypoxia Per Hour","timeFrame":"35, 36, 37, 38 weeks postmenstrual age","effectByArm":[{"arm":"Caffeine","deltaMin":3.6,"sd":4.3},{"arm":"Active Comparator: no Caffeine","deltaMin":8.4,"sd":8.4}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"33 Weeks","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["24445955"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":42},"commonTop":["Tachycardia"]}}